Rapid Novor Inc

𝗖𝗮𝗻 𝗮 𝘀𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗮𝗻𝘁𝗶-𝗶𝗱𝗶𝗼𝘁𝘆𝗽𝗲 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗲 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 𝘁𝗵𝗮𝘁 𝗿𝗶𝘃𝗮𝗹, 𝗼𝗿 𝗲𝘃𝗲𝗻 𝗼𝘂𝘁𝗽𝗲𝗿𝗳𝗼𝗿𝗺 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗿𝗲𝗮𝗴𝗲𝗻𝘁𝘀?

Join us for a live webinar on June 23, where we'll explore how our integrated protein sequencing and characterization workflow can accelerate anti-idiotype discovery while generating antibodies with unmatched performance metrics.

🧪 𝗪𝗲𝗯𝗶𝗻𝗮𝗿: Unbeatable Anti-Idiotype Antibodies: Direct Discovery with Protein Sequencing, SPR, and HDX-MS
📅 𝗗𝗮𝘁𝗲: Tuesday, June 23, 2026
🕚 𝗧𝗶𝗺𝗲: 10:00 AM EST

👇 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝘁𝗼 𝘀𝗮𝘃𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁!
https://hubs.li/Q04jWVfz0

Webinar: Anti-Idiotype Antibody Discovery and Characterization with SPR and HDX-MS In this webinar, you will learn: How integrated protein sequencing, SPR, and HDX-MS workflows can accelerate anti-idiotype antibody discovery pipelines. Strategies to discover all three functional anti-idiotype antibody subtypes with strong functional performance and low cross-reactivity to endogeno...

Heading to ASMS 2026? Check out our poster with the latest HDX-MS data for our anti-idiotype antibody discovery workflow!

📌 Poster presented by Dominic Narang
📅 June 2, 2026
🧪Antibodies & Antibody Drug Conjugates I

🥳 We just celebrated our 11th anniversary!

Only five months in, and this year is already one for the books. EasyM received a provisional licence from the Ontario Ministry of Health (MOH) to provide testing for Canadian patients, and we completed enrollment for the first Canadian prospective clinical study evaluating EasyM; huge wins for our team and for patients across Canada.

We celebrated the only way we know how: with good food and good company (don't worry, we made sure our remote teammates felt included too 😉)

Here's to 11 years of great science and even greater people. Thank you to everyone who has been part of this journey!